The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Malonyl CoA, generated by the enzyme acetyl CoA carboxylase (ACC), represses CPT1 to inhibit acylcarnitine import.53 Malonyl CoA is the initiating metabolite for FAS, and its levels dictate the balance of fat synthesis or oxidation within a cell.”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [53]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Flagged first, then by citations
Research works printed but not linked: 4
- Kraegen, E. W. et al. Insulin resistance induced by glucose infusion is associated temporally with reduced muscle and liver AMPK activity. Diabetes 52, A330 (2003).
- Ido, Y. et al. The AMP-kinase (AMPK) activator, AICAR, inhibits the increase in oxidative stress induced by hyperglycemia and palmitate. Diabetes 51, A396 (2002).
- Ido, Y., Yagihashi, N., Cacicedo, J. M., Ruderman, N. B. AMP-kinase activation prevents TNF-α induced ICAM expression by inhibiting NF-κB transactivation but not by inhibiting their translocation or DNA-binding. Diabetes 51, A458 (2002).
- Sbraccia, P. et al. Rosiglitazone treatment improves insulin sensitivity in lipodystrophic patients with mandibuloacral displasia. Diabetes 52, A1 (2003). · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 456
Cardiac aging: Molecular mechanisms and therapeutic interventions
Li, X., Pang, X., Sun, H., Zhang, B., Wang, H., Wu, N., & Yang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107954 · Cited by 16
Rodríguez, C., Sánchez, A., Medina, J. S., Muñoz, M., Hernández, M., López, M., Rivera, L., Contreras, C., & Prieto, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15600 · Cited by 15
Skeletal muscle fatty acids shift from oxidation to storage upon dexamethasone treatment in chickens
Wang, X. J., Song, Z., Jiao, H., & Lin, H. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.09.013 · Cited by 15
Modulation of Lipid Metabolism by Deep-Sea Water in Cultured Human Liver (HepG2) Cells
He, S., Hao, J., Peng, W., Qiu, P., Li, C., & Guan, H. (2013) · Marine Biotechnology · doi:10.1007/s10126-013-9540-1 · Cited by 15
Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?
Clapham, J. C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9882-1_1 · Cited by 15
Keshavjee, B., Lambelet, V., Coppola, H., Viertl, D., Prior, J. O., Kappeler, L., Armengaud, J.-B., Chouraqui, J.-P., Chehade, H., Vanderriele, P., et al. (2022) · Antioxidants · doi:10.3390/antiox11091695 · Cited by 17
AMP-activated protein kinase and muscle insulin resistance
Edward, W. K. (2009) · Frontiers in bioscience · doi:10.2741/3558 · Cited by 15
Li, Y., Zhao, J., Zheng, H., Zhong, X., Zhou, J., & Hong, Z. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/768540 · Cited by 15
Nirwane, A. M., & Majumdar, A. S. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1391847 · Cited by 15
Ramírez-Zamudio, G. D., Ganga, M. J. G., Pereira, G. L., Nociti, R. P., Chiaratti, M. R., Cooke, R. F., Chardulo, L. A. L., Baldassini, W. A., Neto, O. R. M., & Curi, R. A. (2023) · Metabolites · doi:10.3390/metabo13020160 · Cited by 15
Surveying the Therapeutic Potentials of Isoliquiritigenin (ISL): A Comprehensive Review
Mustafa, A. M., El‐Shiekh, R. A., Esmail, M. M., Hassan, E., Senna, M. M., Ebid, N., & Elgindy, A. M. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500456 · Cited by 14
The neuropeptide substance P/neurokinin‐1 receptor system and diabetes: From mechanism to therapy
Kokabi, F., Ebrahimi, S., Mirzavi, F., Nooghabi, N. G., Hashemi, S. F., & Hashemy, S. I. (2023) · BioFactors · doi:10.1002/biof.1935 · Cited by 14
Functional Variant Disrupts Insulin Induction of USF1
Naukkarinen, J., Nilsson, E., Koistinen, H. A., Söderlund, S., Lyssenko, V., Vaag, A. A., Poulsen, P., Groop, L., Taskinen, M., & Peltonen, L. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.840421 · Cited by 14
Different metabolic responses to central and peripheral injection of enterostatin
Lin, L., Park, M., Hulver, M. W., & York, D. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00045.2005 · Cited by 14
Xu, M., Li, X., Wang, J.-G., Du, P.-F., Hong, J., Gu, W., Zhang, Y., & Ning, G. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.06.012 · Cited by 17
Ling, B.-L., Chiu, C., Lu, H., Lin, J.-J., Kuo, C.-Y., & Chou, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108717 · Cited by 13
Zeng, H.-L., Huang, S., Xie, F., Zeng, L.-M., Hu, Y., & Leng, Y. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.147 · Cited by 13
Lipka, E., Folly‐Klan, M., Charton, J., Vaccher, M., Bonte, J., & Vaccher, C. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.07.023 · Cited by 12
Németh, Z., Kiss, É., & Takács, I. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709253 · Cited by 14
Metabolic fuel utilization and subclinical atherosclerosis in overweight/obese subjects
Montalcini, T., Gazzaruso, C., Ferro, Y., Migliaccio, V., Rotundo, S., Castagna, A., & Pujia, A. (2012) · Endocrine · doi:10.1007/s12020-012-9845-2 · Cited by 12
Dubon, M. J., Byeon, Y., & Park, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4453 · Cited by 12
Li, H., Wang, X., Mao, Y., Hu, R., Xu, W., Lei, Z., Zhou, N., Jin, L., Guo, T., Li, Z., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-24 · Cited by 12
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
Dutta, D., Kalra, S., & Sharma, M. (2016) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.191007 · Cited by 12
Glucagon-like peptide-1 effects lipotoxic oxidative stress by regulating the expression of microRNAs
Zhang, Z., Liu, H., & Li, Q. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.058 · Cited by 12
Hong, S., Lee, J., Park, S. E., Rhee, E., Park, C., Oh, K. W., Park, S. W., & Lee, W. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.553 · Cited by 12
Why Might Thiazolidinediones Increase Exercise Capacity in Patients With Type 2 Diabetes?
LeBrasseur, N. K., & Ruderman, N. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2975 · Cited by 12
Self-citationIwasaki, K., Miwa, Y., Haneda, M., Kuzuya, T., Ogawa, H. K., Ōnishi, A., & Kobayashi, T. (2013) · Transplant International · doi:10.1111/tri.12186 · Cited by 12
Dietary L-arginine supplementation reduces fat mass in diet-induced obese rats
Jobgen, W. S. (2009) · OakTrust (Texas A&M University Libraries) · Cited by 12
Zhang, S., Cui, Z., Zhang, H., Wang, P., Wang, F., & Zhang, J. (2024) · Nutrients · doi:10.3390/nu16142232 · Cited by 12
Zhao, X., Liu, Y., Wang, D., Li, T., Xu, Z., Li, Z., Bai, X., & Wang, Y.-C. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5515 · Cited by 11
Thabah, D., Syiem, D., Pakyntein, C. L., Banerjee, S., Kharshiing, C. E., & Bhattacharjee, A. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1897145 · Cited by 11
AMP-activated protein kinase and its regulation by adiponectin and interleukin-6
Kelly, M., Ruderman, N. B., & Tomás, E. (2006) · Scandinavian Journal of Food & Nutrition · doi:10.1080/17482970601076305 · Cited by 11
Self-citationAbbott, M. J., Constantinescu, S., & Turcotte, L. P. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.064402 · Cited by 11
Fueling the Heart: Multiple Roles for Cardiac Metabolism
Taegtmeyer, H. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_53 · Cited by 11
Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors
Wallace, D. M., Haramura, M., Cheng, J., Arrhenius, T. S., & Nadzan, A. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.023 · Cited by 10
Molecular Mechanism Underlying the Actions of Antioxidant Molecules in Digestive Disorders
Gagnière, J., & Bonnet, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805377-5.00014-x · Cited by 12
Lipka, E., Charton, J., Vaccher, M., Folly‐Klan, M., Bonte, J., & Vaccher, C. (2009) · Journal of Separation Science · doi:10.1002/jssc.200800713 · Cited by 10
Abe, D., Saito, T., & Nogata, Y. (2016) · Food Science and Technology Research · doi:10.3136/fstr.22.779 · Cited by 10
The effects of troglitazone on AMPK in HepG2 cells
Allen, K. M., Coughlan, K. A., Mahmood, F. N., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.05.010 · Cited by 10
Self-citationThe role and function of lncRNA in ageing-associated liver diseases
Zarandi, P. K., Ghiasi, M., & Heiat, M. (2024) · RNA Biology · doi:10.1080/15476286.2024.2440678 · Cited by 10
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
Therapeutically relevant natural products as AMPK activators in the treatment of diabetes
Germán-Acacio, J. M., Meza-Sánchez, D. E., & Morales‐Morales, D. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-817907-9.00003-9 · Cited by 10
Intermediary Metabolism of Carbohydrate, Protein, and Fat
Tornheim, K., & Ruderman, N. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_2 · Cited by 9
Self-citationGuava Leaf Extracts Inhibit 3T3-L1 Adipocyte Differentiation Via Activating AMPK
Yoshitomi, H., Qin, L., Liu, T., & Gao, M. (2013) · Journal of Nutritional Therapeutics · doi:10.6000/1929-5634.2012.01.02.2 · Cited by 9
Patnaik, A., Locasale, J. W., & Cantley, L. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_13 · Cited by 9
Vaccher, M., Charton, J., Guelzim, A., Caignard, D., Bonte, J., & Vaccher, C. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.01.048 · Cited by 9
Figueras, T., Perdicaro, D. J., Cacciamani, V. E., Lorenzo, A. F. G., Suhaiman, L., Antoniolli, A., Prieto, M. A. V., & Costantino, V. V. (2025) · Food & Function · doi:10.1039/d5fo02327k · Cited by 8
Wang, L., Dong, W., Gao, H. F., Chen, C., Liang, S., Ye, X., Liu, Y., Hou, Y., Fan, L., Pan, T., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166560 · Cited by 8
Kwon, Y., Song, P., Yoon, J. H., Ghim, J., Kim, D., Kang, B., Lee, T. G., Kim, J.-A., Choi, J., Youn, I. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108771 · Cited by 9
Hot stuff: thyroid hormones and AMPK
Hardie, D. G. (2010) · Cell Research · doi:10.1038/cr.2010.153 · Cited by 8
Trigger mechanisms in insulin resistance and diabetes mellitus development
Zlatkina, V. V., Карая, О. В., Yarmish, N., & Shalimova, A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.03 · Cited by 8
Malonyl coenzyme A affects insulin-stimulated glucose transport in myotubes
Patil, P. B., Minteer, S. D., Mielke, A., Lewis, L. R., Casmaer, C. A., Barrientos, E. J., Ju, J.-S., Smith, J. L., & Fisher, J. S. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701318542 · Cited by 8
Ramachandran, C., Nair, S. M., Quirrin, K.-W., & Melnick, S. J. (2013) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587213488601 · Cited by 8
Alqudah, S., DeLucia, B., Osborn, L. J., Markley, R. L., Bobba, V., Preston, S. M., Thambidurai, T., Nia, L. H., Fulmer, C. G., Sangwan, N., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102272 · Cited by 10
Park-York, M., Boghossian, S., Oh, H., & York, D. A. (2013) · Brain Research · doi:10.1016/j.brainres.2012.12.042 · Cited by 7
AMP-activated protein kinase and its regulation by adiponectin and interleukin-6
Kelly, M., Ruderman, N. B., & Tomás, E. (2006) · Food & Nutrition Research · doi:10.3402/fnr.v50i0.1581 · Cited by 7
Self-citationKorani, B., Mirzapour, A., Moghadamnia, A. A., Khafri, S., Neamati, N., & Parsian, H. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.40572 · Cited by 7
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7
Self-citationSimon‐Szabó, L., Lizák, B., Sturm, G., Somogyi, A., Takács, I., & Németh, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169113 · Cited by 8
Wang, L., Wu, J., Gao, Y., Lin, D., & Ma, J. (2020) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2020.24.1.19 · Cited by 6
Liu, J., Wu, Y., Liu, S., Gao, Z., Fan, W., Ding, C., Tang, Z., Zhang, S., Shi, X., Tan, L., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110115 · Cited by 6
Lee, Y., Kim, K.-W., Jin, B., Lee, D., Ko, W., Kim, H.-M., Yang, C. Y., Yoon, D., Kim, G., An, H., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105854 · Cited by 6
Frasca, D., & Blomberg, B. B. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017020113 · Cited by 6
Diet-Induced Metabolic Dysfunction of Hypothalamic Nutrient Sensing in Rodents
Arrieta‐Cruz, I., Torres-Ávila, B. S., Martínez‐Coria, H., López-Valdés, H. E., & Juárez, R. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073958 · Cited by 6
The fatty acid oxidation pathway as a therapeutic target for insulin resistance
Clapham, J. C., & Storlien, L. H. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.749 · Cited by 6
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 7
Self-citationAMPK: an enzyme that may be effective in cancer and metabolic diseases
Güney-Kalkan, S., & Ceylan‐Ünlüsoy, M. (2025) · Discover Oncology · doi:10.1007/s12672-025-02229-4 · Cited by 5
Baskaran, R., Chen, Y., Chang, C.-F., Kuo, H.-N., Liang, C.-H., Abomughaid, M. M., Kumar, K. J. S., & Lin, W. (2025) · 3 Biotech · doi:10.1007/s13205-025-04238-0 · Cited by 6
R-α-Lipoic Acid and 4-Phenylbutyric Acid Have Distinct Hypolipidemic Mechanisms in Hepatic Cells
He, B., & Moreau, R. F. (2020) · Biomedicines · doi:10.3390/biomedicines8080289 · Cited by 5
Chilakala, R., Moon, H. J., Kim, K., Yang, S., & Cheong, S. H. (2023) · Physical Activity and Nutrition · doi:10.20463/pan.2023.0018 · Cited by 5
Li, D., Xu, M., Wang, D., Wang, S., & Li, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140585 · Cited by 4
Godfrey, H., Shoveller, A. K. K., Kelly, J., Kostiuk, D., Blades, J. S., & Verbrugghe, A. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf081 · Cited by 4
Platelet metabolism meets thrombosis
Chen, Y., & Silverstein, R. L. (2018) · Blood · doi:10.1182/blood-2018-08-865600 · Cited by 4
Rationale for the use of metformin and exercise to counteract statin‐associated side effects
Haxhi, J., & Thompson, P. D. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13900 · Cited by 4
Rafailovska, E., Tuševski, O., Simic, S. G., Панов, С., Станоева, Ј. П., Dinevska-Ќovkarovska, S., & Miova, B. (2024) · Macedonian Journal of Chemistry and Chemical Engineering · doi:10.20450/mjcce.2024.2849 · Cited by 3
Lin, C., Sun, G., & Li, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00727h · Cited by 3
Akhil, A., Bansal, R., Ankita, A., Kaur, H., Monika, M., & Bhatnagar, A. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101930 · Cited by 3
Effect of Exercise on Neurodegeneration in Neurological Disorders
Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_5 · Cited by 3
Lipka, E., Charton, J., & Vaccher, C. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2992 · Cited by 3
Modulation of DNA/RNA Methylation Signaling Mediating Metabolic Homeostasis in Cancer
Choubey, P., Kaur, H., & Bansal, K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_7 · Cited by 3
Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes
Mendler, M., Kopf, S., Groener, J. B., Riedinger, C., Fleming, T. H., Nawroth, P. P., & Okun, J. G. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1130-2 · Cited by 3
Monoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
Self-citationRao, S. J. A., Gollapalli, P., & Shetty, N. P. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2122567 · Cited by 2
Zou, M., & Wu, S. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000009 · Cited by 2
Suffi, N., Franco, F. N., Chaves, M. M., & de Araújo, G. R. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n2-080 · Cited by 2
KİSMİROĞLU, C., & Yaman, M. (2020) · European Journal of Science and Technology · doi:10.31590/ejosat.746132 · Cited by 2
Chapter 11 Lipid-Metabolizing Enzymes as Targets for Dyslipidemia and Insulin Resistance
Yeh, V. S. C., Judd, A. S., & Souers, A. J. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42011-5 · Cited by 2
Le paradoxe de l’obèse insulino-sensible
Chabot, K., RABASA-LHORET, R. P. R., & Gauthier, M. (2012) · Obésité · doi:10.1007/s11690-012-0318-9 · Cited by 2
Antunes, M. M., & Bazotte, R. B. (2015) · SaBios-Revista de Saúde e Biologia · Cited by 2
Alqudah, S., DeLucia, B., Osborn, L. J., Markley, R. L., Bobba, V., Preston, S. M., Thambidurai, T., Nia, L. H., Fulmer, C. G., Sangwan, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.18.654739 · Cited by 2
SCREENING THE INFLUENCE OF DILTIAZEM ON ORAL ANTIDIABETIC AGENTS IN EXPERIMENTAL ANIMALS
Suresh, D. K., Vibhute, A., & Imad Uddin, M. D. (2022) · INDIAN DRUGS · doi:10.53879/id.59.03.12737 · Cited by 1
Byrnes, J. J. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48040346 · Cited by 1
Influencing energy expenditure and substrate utilisation
Clapham, J. C., & Arch, J. R. S. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7425-9_8 · Cited by 1
Danial, N. N. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976094.019 · Cited by 1
Insulina, hipoglucemiantes orales y propiedades farmacológicas del páncreas endocrino
Davis, S. N. (2006) · Dialnet (Universidad de la Rioja) · Cited by 1
Mostafa, A. F., & Adel, M. (2014) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2014.34830 · Cited by 1
Alqahtani, A., Holly, J. M. P., & Perks, C. M. (2022) · Journal of cancer research updates · doi:10.30683/1929-2279.2022.11.02 · Cited by 1
Non alcoholic fatty liver disease (NAFLD): an overview
McAvoy, N., Lockman, A., & Hayes, P. C. (2007) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520073701003 · Cited by 1
Post-Genomic Analysis of Fatty Acid and Glucose Metabolism in Cardiovascular Disease
Marín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00016-0 · Cited by 1
Drug Treatment in the Metabolic Syndrome
Karathanasis, S. K., & SCHIEBINGER, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50027-9 · Cited by 1
Metadata
- Authors
- Ruderman, N., & Prentki, M.
- Affiliations
- Boston University (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-04-01
- Volume
- 3
- Issue
- 4
- Pages
- 340-351
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1983336199
- Semantic Scholar
- ff013aa7272ad9b1a90aa52d7a0383e343b6f8ec
- Cited by
- 451
- References
- 168
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 12 · 2023: 11 · 2022: 23 · 2021: 17 · 2020: 19 · 2019: 21 · 2018: 13 · 2017: 22 · 2016: 19 · 2015: 14 · 2014: 27 · 2013: 22 · 2012: 21
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- AMPK, malonyl-CoA, metabolic syndrome, insulin resistance, obesity, fatty acid metabolism, ectopic fat deposition, AMPK activators, therapeutic target, type 2 diabetes, atherosclerosis
- MeSH terms
- Adenylate Kinase, Animals, Fatty Acids, Humans, Malonyl Coenzyme A, Signal Transduction, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review